The hedamycin locus implicates a novel aromatic PKS priming mechanism

Tsion Bililign1, Chang-Gu Hyun, Jessica S Williams

  • 1Laboratory for Biosynthetic Chemistry, Pharmaceutical Sciences Division, School of Pharmacy, University of Wisconsin-Madison, 777 Highland Avenue, Madison, Wisconsin 53705, USA.

Chemistry & Biology
|July 24, 2004
PubMed

Insights

Researchers cloned the hedamycin biosynthetic gene cluster from Streptomyces griseoruber. This study reveals a novel iterative type I polyketide synthase (PKS) system priming a type II PKS for pluramycin antibiotic production.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Biochemistry

Background:

  • Pluramycin-type antibiotics, like hedamycin, exhibit antitumor properties.
  • Understanding the biosynthesis of these complex molecules is crucial for drug development.

Purpose of the Study:

  • To clone and analyze the biosynthetic gene cluster of the pluramycin-type antitumor antibiotic hedamycin.
  • To elucidate the polyketide synthase (PKS) system involved in hedamycin biosynthesis.

Main Methods:

  • Cloning of the hedamycin biosynthetic gene cluster from Streptomyces griseoruber.
  • Sequence analysis of the 45.6 kb gene cluster.
  • Gene disruption experiments to confirm gene function.

Main Results:

  • Identification of unique features including a fabH homolog (KSIII), acyltransferase (AT) gene, type I PKS genes, and C-glycosyltransferase genes.
  • The study is the first to report the cloning of a pluramycin biosynthetic gene cluster.
  • Gene disruption confirmed the essential roles of both type I and type II PKS genes in hedamycin biosynthesis.

Conclusions:

  • Hedamycin biosynthesis involves an iterative type I PKS system for a novel starter unit that primes a type II PKS system.
  • A second catalytic ketosynthase (KSIII) appears to regulate this unusual priming step.
  • This research provides significant insights into the complex PKS machinery underlying pluramycin antibiotic production.